Axcelis Technologies Earnings Call Transcripts
Fiscal Year 2025
-
Q4 and full-year 2025 results exceeded expectations, driven by strong CS&I aftermarket revenue and favorable mix, while memory demand—especially DRAM—showed sequential improvement. 2026 revenue is expected to be flat, with memory growth offsetting declines in power and general mature markets, and the Veeco merger progressing toward a second-half 2026 close.
-
Q3 2025 revenue and non-GAAP EPS exceeded expectations, driven by record CS&I revenue and strong system sales. The pending Veeco merger aims to expand capabilities and market reach, while memory and silicon carbide segments show growth potential for 2026.
-
A transformational all-stock merger will create a leading U.S. semiconductor equipment supplier with a broad, complementary product portfolio and expanded market reach. The deal targets $35 million in cost synergies within two years, is expected to be accretive to non-GAAP EPS in year one, and positions the combined company for growth in AI, power electronics, and advanced packaging.
-
Q2 2025 saw revenue and EPS exceed expectations, with strong gross margins and robust CSNI performance. Power segment, especially SiC in China, remained resilient, while memory and general mature segments were muted. Guidance points to stable revenue and margins in the second half.
-
The company, a leading ion implantation provider, reported $1B in 2024 revenue and is expanding in power and mature semiconductor markets, driven by silicon carbide adoption and electrification trends. Strong cash flow, disciplined cost control, and increased R&D support growth in underpenetrated regions and advanced logic.
-
Q1 2025 results exceeded expectations with strong gross margins, disciplined cost control, and robust free cash flow. Guidance for Q2 anticipates lower revenue and margins due to mix, but profitability and cash generation remain solid. Share repurchases and a strong balance sheet support ongoing investment and growth.
-
Export controls are expected to have a limited revenue impact due to prior strategic moves, while Silicon Carbide adoption is accelerating across EVs and industrial sectors as costs fall. Gross margin targets above 45% are supported by product differentiation and supply chain improvements, with growth focused on SiC, memory, advanced logic, and Japan.
Fiscal Year 2024
-
Q4 and full-year 2024 results exceeded expectations on strong CS&I sales and margin improvement, despite lower system sales. 2025 revenue is expected to decline, with a stronger second half anticipated, and continued investment in R&D and geographic expansion planned.
-
Q3 2024 revenue was $256.6M with EPS of $1.49, driven by strong image sensor demand in China, while power and general mature markets softened. Bookings and backlog declined, and management expects lower revenue in H1 2025 due to capacity digestion, especially in China.
-
Q2 revenue and EPS exceeded expectations, driven by strong silicon carbide demand and evaluation unit conversions. Power segment led growth, while memory and general mature segments are expected to recover gradually, supporting a positive long-term outlook.
-
Management outlined a strategy centered on ion implantation for power, AI, and electrification markets, targeting $1.6B revenue by 2027 with margin expansion and robust R&D. Growth will be driven by silicon carbide, geographic expansion, and new product extensions, with aftermarket and advanced logic as incremental contributors.
-
Ion implant equipment demand is rebounding, with power devices and aftermarket services driving strong margins. Memory market recovery is expected to begin in Q4 2024, while AI and EV trends support long-term growth. Competitive position remains strong, with new growth plans to be detailed at the July Investor Day.
-
Ion implantation market growth is driven by mature technologies, electrification, and AI, with strong global positioning and a robust product portfolio. Financial outlook is positive, with margin expansion from product differentiation and expected memory market recovery in 2024-2025.